Piramal Pharma

{
  "main_header": {
    "sid": 1003728,
    "name": "Piramal Pharma",
    "stock_name": "Piramal Pharma",
    "full_name": "Piramal Pharma Ltd",
    "name_url": "stocks-analysis/piramal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "171.50",
    "chg": -1.75,
    "chgp": "-1.01%",
    "dir": -1,
    "prev_price": "173.25",
    "mcapval": "22,796.61 Cr",
    "mcap": "Small Cap",
    "scripcode": 543635,
    "symbol": "PPLPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0DK501011",
    "curr_date": "May 20",
    "curr_time": "",
    "bse_nse_vol": "8.22 lacs",
    "exc_status": "Active",
    "traded_date": "May 20, 2026",
    "traded_date_str": "2026 05 20",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/piramal-pharma-1003728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Piramal Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-ltd-is-rated-sell-by-marketsmojo-3989390",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_mojoScore_3989390.png",
        "date": "2026-05-13 10:10:03",
        "description": "Piramal Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3986688",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_technicaldot_3986688.png",
        "date": "2026-05-12 08:08:54",
        "description": "Piramal Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent day gain of 2.39% to close at ₹184.05, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory."
      },
      {
        "title": "Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3984814",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_technicaldot_3984814.png",
        "date": "2026-05-11 08:03:23",
        "description": "Piramal Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade to a Sell rating, the stock’s mixed technical profile and relative outperformance over various time frames warrant a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Piramal Pharma Gains 12.13%: 5 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-gains-1213-5-key-factors-driving-the-weeks-rally-3982997",
        "imagepath": "",
        "date": "2026-05-09 11:02:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Flat quarterly financial trend reported amid mixed performance</p>\n                    <p><strong>5 May:</strong> Technical momentum shifts with mildly bearish signals</p>\n                    <p><strong>7 May:</strong> Intraday high surge of 8.42% and exceptional volume spike</p>\n                    <p><strong>7 May:</strong> Surge in value trading and institutional interest</p>\n                    <p><strong>7 May:</strong> Exceptional volume surge amid strong price rally</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.160.30</div></div>..."
      },
      {
        "title": "Piramal Pharma Ltd Sees Exceptional Volume Surge Amid Strong Price Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-sees-exceptional-volume-surge-amid-strong-price-rally-3979822",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_most_active_equities_by_volume_3979822.png",
        "date": "2026-05-07 12:00:06",
        "description": "Piramal Pharma Ltd (PPLPHARMA) has emerged as one of the most actively traded stocks on 7 May 2026, registering a remarkable surge in volume and price amidst heightened volatility. The pharmaceutical and biotechnology small-cap stock outperformed its sector and broader market indices, signalling strong investor interest despite a recent downgrade in its mojo grade from Hold to Sell."
      },
      {
        "title": "Piramal Pharma Ltd Sees Surge in Value Trading Amid Volatility and Institutional Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-sees-surge-in-value-trading-amid-volatility-and-institutional-interest-3979824",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_most_active_equities_by_value_3979824.png",
        "date": "2026-05-07 12:00:05",
        "description": "Piramal Pharma Ltd (PPLPHARMA) emerged as one of the most actively traded stocks by value on 7 May 2026, registering a remarkable 12.39% intraday gain and outperforming its sector by over 14%. The pharmaceutical small-cap has attracted significant institutional interest, with trading volumes soaring to nearly 3 crore shares and a total traded value exceeding ₹551 crore, signalling heightened investor participation amid volatile market conditions."
      },
      {
        "title": "Piramal Pharma Ltd Surges 8.42% to Day's High of Rs 175.7 — Outperforms Sector by 6.05 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-hits-intraday-high-with-842-surge-on-7-may-2026-3979764",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_priceRelatedfactors_3979764.png",
        "date": "2026-05-07 11:16:01",
        "description": "The Sensex declined 0.18% on 7 May 2026, while Piramal Pharma Ltd surged 8.42%, outperforming its Pharmaceuticals &amp; Biotechnology sector by 6.05 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop."
      },
      {
        "title": "Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3975027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_technicaldot_3975027.png",
        "date": "2026-05-05 08:08:02",
        "description": "Piramal Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish signals on weekly charts, monthly indicators suggest caution, reflecting a complex interplay of momentum and trend signals that investors should carefully analyse."
      },
      {
        "title": "Piramal Pharma Ltd Reports Flat Quarterly Financial Trend Amid Mixed Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-reports-flat-quarterly-financial-trend-amid-mixed-performance-3973386",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_fintrenddot_3973386.png",
        "date": "2026-05-04 08:00:14",
        "description": "Piramal Pharma Ltd’s latest quarterly results for March 2026 reveal a shift from previously positive financial trends to a flat performance, despite notable growth in net sales and profit before tax. The company’s financial health presents a complex picture, with strong operational metrics contrasting with subdued returns and elevated leverage, prompting a downgrade in its Mojo Grade to Sell."
      }
    ],
    "total": 447,
    "sid": "1003728",
    "stock_news_url": "https://www.marketsmojo.com/news/piramal-pharma-1003728"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Successful Closure Of US FDA Inspection At Piramal PharmaS Manufacturing Facility Located At Digwal Telangana India",
      "datetime": "18-May-2026",
      "details": "Please refer attached file",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "10-May-2026",
      "details": "Please refer attached file",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "04-May-2026",
      "details": "Intimation of Schedule of Analyst/ Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has declared <strong>1%</strong> dividend, ex-date: 16 Jul 25",
          "dt": "2025-07-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has announced <strong>5:46</strong> rights issue, ex-date: 02 Aug 23",
          "dt": "2023-08-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Piramal Pharma Ltd is Rated Sell by MarketsMOJO

2026-05-13 10:10:03

Piramal Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-12 08:08:54

Piramal Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent day gain of 2.39% to close at ₹184.05, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory.

Read full news article

Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-11 08:03:23

Piramal Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade to a Sell rating, the stock’s mixed technical profile and relative outperformance over various time frames warrant a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Piramal Pharma Gains 12.13%: 5 Key Factors Driving the Week’s Rally

2026-05-09 11:02:14

Key Events This Week

4 May: Flat quarterly financial trend reported amid mixed performance

5 May: Technical momentum shifts with mildly bearish signals

7 May: Intraday high surge of 8.42% and exceptional volume spike

7 May: Surge in value trading and institutional interest

7 May: Exceptional volume surge amid strong price rally

Week Open

Rs.160.30

...

Read full news article

Piramal Pharma Ltd Sees Exceptional Volume Surge Amid Strong Price Rally

2026-05-07 12:00:06

Piramal Pharma Ltd (PPLPHARMA) has emerged as one of the most actively traded stocks on 7 May 2026, registering a remarkable surge in volume and price amidst heightened volatility. The pharmaceutical and biotechnology small-cap stock outperformed its sector and broader market indices, signalling strong investor interest despite a recent downgrade in its mojo grade from Hold to Sell.

Read full news article

Piramal Pharma Ltd Sees Surge in Value Trading Amid Volatility and Institutional Interest

2026-05-07 12:00:05

Piramal Pharma Ltd (PPLPHARMA) emerged as one of the most actively traded stocks by value on 7 May 2026, registering a remarkable 12.39% intraday gain and outperforming its sector by over 14%. The pharmaceutical small-cap has attracted significant institutional interest, with trading volumes soaring to nearly 3 crore shares and a total traded value exceeding ₹551 crore, signalling heightened investor participation amid volatile market conditions.

Read full news article

Piramal Pharma Ltd Surges 8.42% to Day's High of Rs 175.7 — Outperforms Sector by 6.05 Percentage Points

2026-05-07 11:16:01

The Sensex declined 0.18% on 7 May 2026, while Piramal Pharma Ltd surged 8.42%, outperforming its Pharmaceuticals & Biotechnology sector by 6.05 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.

Read full news article

Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-05 08:08:02

Piramal Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish signals on weekly charts, monthly indicators suggest caution, reflecting a complex interplay of momentum and trend signals that investors should carefully analyse.

Read full news article

Piramal Pharma Ltd Reports Flat Quarterly Financial Trend Amid Mixed Performance

2026-05-04 08:00:14

Piramal Pharma Ltd’s latest quarterly results for March 2026 reveal a shift from previously positive financial trends to a flat performance, despite notable growth in net sales and profit before tax. The company’s financial health presents a complex picture, with strong operational metrics contrasting with subdued returns and elevated leverage, prompting a downgrade in its Mojo Grade to Sell.

Read full news article

View All News